Mindfulness-Based Stress Reduction for Mothers with Preterm Infants
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if an 8-week mindfulness program focused on self-compassion (Mindfulness-Based Stress Reduction with Self-Compassion, or MBSC) or a daily vitamin D supplement can reduce stress and boost self-compassion in mothers with preterm infants. Researchers are also examining how these treatments might improve breast milk quality and benefit infants' health. The study includes three groups: one receiving mindfulness training, another taking vitamin D gummies, and a control group with no immediate intervention. Mothers with newborns in the Kootenai Health NICU or the Palouse region are eligible to join. As an unphased trial, this study provides a unique opportunity to explore innovative approaches to enhance maternal and infant well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Mindfulness-Based Self-Compassion (MBSC) is generally safe for participants. In earlier studies, mothers who joined mindfulness programs reported feeling calmer and more connected, with no major side effects, suggesting that MBSC is well-tolerated.
Vitamin D, a common supplement, is usually safe at doses like 2000 IU per day. Although very high doses can cause problems, the amount used in this study is safe for most people.
Both treatments have demonstrated safety in previous research, making them promising options for this study.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the mindfulness-based intervention with a focus on self-compassion (MBSC) because it takes a unique approach to stress reduction for mothers with preterm infants. Unlike traditional therapies that might rely on medication or cognitive behavioral therapy, MBSC emphasizes self-compassion through daily mindfulness practices and guided meditations. This intervention aims to empower mothers by fostering a supportive community with group video sessions led by a certified facilitator. Additionally, the inclusion of Vitamin D gummies as an experimental arm acknowledges the potential role of nutrition in supporting mental health. This holistic approach could offer a novel pathway to improving well-being in a population that often experiences high stress levels.
What evidence suggests that this trial's treatments could be effective for reducing stress in mothers of preterm infants?
Research has shown that mindfulness-based self-compassion (MBSC), one of the treatments studied in this trial, can help reduce stress and anxiety in mothers, particularly those facing challenges like having a premature baby. A review of studies found that mindfulness and relaxation techniques significantly lower stress, anxiety, and depression in mothers with babies in neonatal intensive care units. Mothers participating in mindfulness programs reported feeling calmer and more connected, suggesting mindfulness as an effective way to manage stress. However, one study found that mindfulness exercises alone might not reduce stress for all parents of premature babies. These mixed results highlight the potential benefits of MBSC while acknowledging it might not work for everyone. Another arm of this trial evaluates the effects of Vitamin D supplementation, tested for its potential impact on stress and well-being.23678
Who Is on the Research Team?
Yimin Chen, PhD
Principal Investigator
University of Idaho
Are You a Good Fit for This Trial?
This trial is for mothers of preterm infants born before 36 weeks gestation at Oregon Health and Sciences University. It's designed to help those experiencing stress postpartum, aiming to improve both maternal mental health and infant outcomes.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into control, mindfulness intervention, or vitamin D supplementation groups for 8 weeks
Follow-up
Participants are monitored for changes in stress, self-compassion, and human milk composition
What Are the Treatments Tested in This Trial?
Interventions
- MBSC
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Idaho
Lead Sponsor
Oregon Health and Science University
Collaborator
National Institute of General Medical Sciences (NIGMS)
Collaborator
Oregon State University
Collaborator
Kootenai Health
Collaborator